Your email has been successfully added to our mailing list.

×
-0.00252228014124778 -0.00218597612241471 -0.00285858416008074 -0.00252228014124778 -0.00487640827307897 -0.0099209685555743 -0.0099209685555743 -0.0099209685555743
Stock impact report

Immunovant: Switching Lead Candidates Increases Risk [Seeking Alpha]

Immunovant, Inc. (IMVT) 
Company Research Source: Seeking Alpha
Play 8min Summary Immunovant, Inc. switched focus from batoclimab to IMVT-1402, an anti-FcRn monoclonal antibody, to avoid cholesterol-related side effects. IMVT-1402 shows promise in reducing IgG antibodies without increasing LDL cholesterol, but it is still in early-stage trials. The company faces high R&D expenses and a limited cash runway, risking dilution before reaching regulatory approval. The switch to IMVT-1402 introduces significant uncertainty, making it prudent to avoid investing in IMVT at this stage. Klaus Vedfelt Immunovant, Inc. NASDAQ: IMVT ) is a pharmaceutical company developing targeted therapies for various autoimmune diseases. Batoclimab used to be their lead product candidate, and it is in late-stage trials. It has been replaced by IMVT-1402, a much earlier stage molecule About the TPT service Thanks for reading. At the Total Pharma Tracker , we offer the following:- Our Android app and website features a set of tools for DIY investors, in Show less Read more
Impact Snapshot
Event Time:
IMVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
IMVT alerts

from News Quantified
Opt-in for
IMVT alerts

from News Quantified